Day One Bio­phar­ma­ceu­ti­cals inks re­search col­lab­o­ra­tion with Swedish biotech

Day One Bio­phar­ma­ceu­ti­cals se­cured a re­search and li­cens­ing deal with Sprint Bio­science in a bid to build out its can­cer-fight­ing ar­se­nal.

The Bay Area biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER